In the UKPDS, 3867 patients with newly diagnosed diabetes mellitus type 2 were randomly assigned to an intensive glucose-lowering strategy with sulfonylurea derivates or insulin versus a conventional glucose-lowering strategy with diet [13]. Here, INS is linked to type 2 diabetes mellitus.